Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate

The Longest Day

The day with the most light is the day we fight.

Start your fundraiser by Feb. 29 to get an upgraded T-shirt!

Join the Fight
Turn Your Favorite Activity Into a Fundraiser to End Alzheimer’s

Alzheimer's Association Statement Regarding Washington Post Article on Pfizer/Amgen Enbrel Decision in Alzheimer’s

Alzheimer's Association Statement Regarding Washington Post Article on Pfizer/Amgen Enbrel Decision in Alzheimer’s
Share or Print this page
Share or Print this page
June 5, 2019
Email: media@alz.org
Share or Print this page
CHICAGO, June 5, 2019 — “Any science that has promise for Alzheimer’s disease and other dementias and is not genuinely pursued, or shared with the research community, does a disservice to the millions of individuals facing the disease today and in the future. Alzheimer's is a personally devastating and fatal disease, the sixth leading cause of death in the United States, with the number of people impacted by the disease increasing daily. No stone should be left unturned. The expectation of the Alzheimer’s Association and our millions of constituents is that every possible path is pursued thoroughly and aggressively with people living with the disease as a priority.”

— Maria C. Carrillo, Ph.D., chief science officer, Alzheimer’s Association
 

Alzheimer's Association

The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.

Keep Up With Alzheimer’s News and Events